Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients

Details for Australian Patent Application No. 2004290925 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Waldeck, Harald; Thormaehlen, Dirk; Hocher, Berthold

Agent Watermark

Pub. Number AU-B-2004290925

PCT Pub. Number WO2005/049035

Priority 03104264.1 18.11.03 EP

Filing date 15 November 2004

Wipo publication date 2 June 2005

Acceptance publication date 1 July 2010

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/049035 Priority application(s): WO2005/049035

1 July 2010 Application Accepted

  Published as AU-B-2004290925

28 October 2010 Standard Patent Sealed

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290943-Vaccine composition admixed with an alkylphosphatidylcholine

2004290918-Chimeric anti CD44 antibodies and their use for treating acute myeloid leukemia